Sameer Ralhan's Insider Trades & SAST Disclosures
Sameer Ralhan's most recent trade in Veralto Corp was a trade of 18,704 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sameer Ralhan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Veralto Corp | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 18,704 | 18,704 | - | - | Employee Stock Option (Right to Buy) | |
| Veralto Corp | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 6,767 | 53,047 | - | 0 | Common Stock | |
| Veralto Corp | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 703 | 906 | - | - | Veralto Excess Contribution Program - Veralto Stock Fund | |
| Veralto Corp | Sameer Ralhan | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.68 per share. | 18 Nov 2024 | 3,833 | 46,280 | - | 102.7 | 393,572 | Common Stock |
| Veralto Corp | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 203 | 203 | - | - | Executive Deferred Incentive Program (Veralto Stock Fund) | |
| Veralto Corp | Ralhan Sameer | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2024 | 17,976 | 17,976 | - | - | Employee Stock Option (Right to Buy) | |
| Veralto Corp | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2024 | 7,497 | 50,113 | - | 0 | Common Stock | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 28,807 | 28,807 | - | - | Performance Stock Option (Right to Buy) | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 98,360 | 412,928 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.35 per share. | 10 Feb 2023 | 42,218 | 370,710 (0%) | 0% | 34.3 | 1,450,188 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 35,188 | 20,175 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Sale of securities on an exchange or to another person at price $ 40.14 per share. | 06 May 2022 | 35,188 | 313,506 (0%) | 0% | 40.1 | 1,412,446 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 06 May 2022 | 35,188 | 348,694 (0%) | 0% | 5.4 | 190,015 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 20,175 | 0 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Sale of securities on an exchange or to another person at price $ 40.01 per share. | 06 May 2022 | 20,175 | 313,506 (0%) | 0% | 40.0 | 807,202 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 06 May 2022 | 20,175 | 333,681 (0%) | 0% | 5.4 | 108,945 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 65,722 | 65,722 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 6,254 | 313,091 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.98 per share. | 01 Mar 2022 | 550 | 306,837 (0%) | 0% | 26.0 | 14,289 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 11,864 | 311,363 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.00 per share. | 11 Feb 2022 | 3,975 | 307,388 (0%) | 0% | 30 | 119,250 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 17,482 | 0 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Sale of securities on an exchange or to another person at price $ 29.85 per share. | 02 Dec 2021 | 17,482 | 299,149 (0%) | 0% | 29.9 | 521,838 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.45 per share. | 02 Dec 2021 | 17,482 | 316,631 (0%) | 0% | 18.5 | 322,543 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2021 | 1,890 | 17,482 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 30 Aug 2021 | 1,890 | 298,792 (0%) | 0% | 35 | 66,150 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.45 per share. | 30 Aug 2021 | 1,890 | 300,682 (0%) | 0% | 18.5 | 34,871 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2021 | 15,085 | 19,372 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 27 Aug 2021 | 15,085 | 298,792 (0%) | 0% | 35 | 527,975 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.45 per share. | 27 Aug 2021 | 15,085 | 313,877 (0%) | 0% | 18.4 | 278,318 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 49,079 | 49,079 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 4,997 | 298,116 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 597 | 293,343 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Sameer Ralhan | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.14 per share. | 12 Feb 2021 | 224 | 293,119 (0%) | 0% | 26.1 | 5,855 | Common Stock |
| Chemours Company | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 39,510 | 292,647 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges